The Promise and Challenges of Augmented and Virtual Reality in Medicine

Image Credit: © Chaosamran_Studio - stock.adobe.com

Virtual and augmented reality (VR/AR) technologies are increasingly being integrated into various medical fields, including dermatology.¹ These advanced tools have demonstrated their effectiveness in patient education, surgical planning, and diagnostics. However, their application in dermatological drug discovery holds particular promise. By enabling detailed visualizations, personalized treatments, and improved clinical trials, VR/AR technologies may significantly accelerate the drug development process and enhance patient outcomes. Recent research provided an overview of the potential benefits and challenges associated with the adoption of VR/AR in medicine.²

"Despite the progress, we still have a lot of work to do in this space,” Leon Kircik, MD, lead investigator on the research told Dermatology Times.

Understanding VR and AR in Medicine

Researchers clarified that VR generates immersive digital environments where users can interact with and manipulate virtual objects, whereas AR overlays digital information onto the real world, enhancing perception and understanding. These technologies have been successfully applied in medical training and surgical simulations. In dermatology, researchers stated VR and AR offer valuable insights into skin diseases, drug interactions, and treatment effects, paving the way for innovative therapeutic strategies.

Applications in Dermatological Drug Discovery

The conventional drug discovery process is time-consuming, costly, and resource-intensive. According to the review, VR/AR technologies present a viable alternative by allowing researchers to visualize intricate 3D models of skin anatomy, cellular structures, and molecular interactions. For example, VR can recreate disease models such as psoriasis or eczema, enabling the simulation of drug responses in a controlled virtual setting. This capability reduces dependence on traditional wet-lab experiments and animal models, thereby streamlining preclinical research.

A notable application of AR in drug discovery involves molecular docking visualization. Researchers stated AR tools like Molecular Rift facilitate interaction with 3D molecular models, enhancing the understanding of drug-target interactions. By simulating drug penetration and cellular responses, AR enables the optimization of compound formulations before progressing to clinical trials.

Advancing Personalized Medicine

Given the variability in skin structure and function across individuals, researchers recognized personalized treatments are essential in dermatology. They noted VR/AR technologies contribute to this endeavor by generating patient-specific 3D models based on imaging data such as biopsies. These models allow researchers to simulate drug interactions tailored to an individual's unique skin composition, thereby improving treatment efficacy. VR platforms like Nanome support collaborative molecular exploration, advancing the design of personalized therapies.

Improving Clinical Trials

The review statedVR/AR technologies offer significant advantages in optimizing clinical trial design and implementation. Researchers suggested AR can be utilized to monitor treatment effects by overlaying digital data onto patients' skin, enabling real-time visualization of lesion changes and drug absorption. Medical research tools such as Microsoft's HoloLens have been employed to track disease progression and assess treatment responses. Additionally, VR enhances patient engagement by providing educational modules that improve comprehension of clinical trial procedures, potentially increasing recruitment and retention rates.

Regulatory and Ethical Considerations

The review noted that integration of VR/AR into dermatological research raises important regulatory and ethical concerns. Key challenges include data privacy, informed consent, and equitable access to these technologies. Researchers stated the development of clear regulatory frameworks is necessary to ensure the safe and ethical use of VR/AR in clinical practice. Guidelines must address data security measures and ethical considerations to protect patient confidentiality and promote responsible implementation.

Real-World Applications and Future Directions

Although VR/AR in dermatological drug discovery remains in its early stages, the review noted practical applications are emerging. VR platforms are being used to train dermatologists in complex procedures, while AR tools assist in visualizing treatment outcomes. Companies such as VRHealth and EchoPixel are actively developing VR/AR solutions for medical applications, demonstrating the feasibility of these technologies in real-world settings.

Collaboration among clinicians, researchers, and technologists will be essential to fully realize the potential of VR/AR in drug discovery. Addressing technical challenges, such as creating high-fidelity virtual models of skin diseases and navigating regulatory hurdles, will be crucial for the widespread adoption of these technologies.

Conclusion

The review stated VR and AR represent transformative tools in dermatological drug discovery. By enhancing preclinical research, facilitating personalized treatments, and optimizing clinical trials, researchers suggested these technologies have the potential to revolutionize the treatment of skin diseases. Continued research, innovation, and collaboration will be key to successfully integrating VR/AR into dermatology, ultimately leading to improved patient outcomes and more efficient drug development processes.

References

1. Muralidharan V, Tran MM, Barrios L, et al. Best practices for research in virtual and augmented reality in dermatology. J Invest Dermatol. 2024;144(1):17-23. doi:10.1016/j.jid.2023.10.014
2. Kircik L, Goldust M. The role of virtual and augmented reality in advancing drug discovery in dermatology. J Cosmet Dermatol. 2025 Feb;24(2):e70071. doi: 10.1111/jocd.70071. PMID: 39968690; PMCID: PMC11836915.